AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CHESNARA PLC

Regulatory Filings Apr 8, 2022

5301_rns_2022-04-08_266878df-71f1-41b8-8539-f45aa070486b.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6995H

Chesnara PLC

08 April 2022

LEI Number: 213800VFRMBRTSZ3SJ06

08 April 2022

CHESNARA plc

("Chesnara" or "the Company")

ACQUISITION UPDATE

REGULATORY APPROVAL  

Chesnara plc ('The Company') announced on 13 September 2021 the proposed acquisition of Sanlam Life & Pensions UK Limited for £39m.

The Company is pleased to announce that the proposed acquisition has received UK regulatory approval and work will now progress with a view to completing in the coming weeks.

For further information, please contact:

Roddy Watt

Director, Capital Markets

FWD

Forward thinking communications

T   -    020 7280 0651  

E   -    [email protected] 

Notes to Editors

Chesnara is a life and pensions company listed on the London Stock Exchange.  It administers approximately 960,000 policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

Following a three pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 17 years in succession.

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACQIRMATMTMMBIT

Talk to a Data Expert

Have a question? We'll get back to you promptly.